XORTX Therapeutics, Inc. XRTX 深 沪
已收盘 05-08 16:00:00 美东时间
2.79
+0.140
+5.28%
华盛通- 最 高2.79
- 今 开2.60
- 成交量 1.74万股
- 最 低 2.60
- 昨 收 2.65
- 总市值 431.61万
- 52周最高 7.05
- 市盈率 静 --
- 换手率 1.12%
- 52周最低 1.725
- 委 比 12.59%
- 总股本 154.70万
- 历史最高 265.05
- 量 比 0.85
- 振 幅 7.17%
- 历史最低 1.725
- 每 手 1
- 风险率 0.96%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Scinai Immunotherapeutics (NASDAQ:SCNI) shares moved upwards by 145.6%...
04-24 20:05
XORTX Therapeutics Receives Letter Of Compliance From Nasdaq
XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU))), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney
04-21 19:21
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers XORTX Therapeutics (NASDAQ:XRTX) shares increased by 53.8% to $3.4 dur...
04-14 05:05
XORTX Therapeutics Delays 1-for-5 Share Consolidation To April 6, Pending Approvals
XORTX Therapeutics Inc. ("XORTX" or the "Company") (NASDAQ:XRTX, TSXV:XRTX, Frankfurt: ANU))), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive
03-27 04:42
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Can Fite Biopharma (AMEX:CANF) stock rose 17.6% to $5.88 during Wednes...
03-04 20:05
Why Align Technology Shares Are Trading Higher By Over 10%; Here Are 20 Stocks Moving Premarket
Shares of Align Technology Inc (NASDAQ:ALGN) rose sharply in pre-market trading...
02-05 17:34
Why Lucas GC Shares Are Trading Higher By Over 36%; Here Are 20 Stocks Moving Premarket
Shares of Lucas GC Limited (NASDAQ:LGCL) rose sharply in pre-market trading aft...
2025-11-03 18:09
XORTX Therapeutics Announces US$1.1 Million Direct Offering
XORTX Therapeutics Inc ( ($TSE:XRTX) ) has provided an update. On October 21, 2...
2025-10-21 20:27
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Replimune Group (NASDAQ:REPL) shares rose 119.1% to $9.86 during Monda...
2025-10-21 02:39
XORTX Issues Correction Notice and XORTX Announces 180-Day Extension to Regain Compliance with Nasdaq Minimum Bid Price Deficiency
XORTX Therapeutics received a notice from Nasdaq granting a 180-day extension to meet the minimum bid price requirement of US$1.00 per share by April 13, 2026. If compliance is not achieved, the company may face delisting and could appeal the decision. XORTX continues to develop therapies for gout, progressive kidney disease, and acute kidney injury.
2025-10-21 00:34
